ArticleMolecular and clinical oncology2020

A comparative study of nivolumab and axitinib in terms of overall survival, treatment continuation, and cost for patients with metastatic renal cell carcinoma.

Michio Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.